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Abstract
Background: Vitamin D deficiency is associated with a variety of chronic metabolic diseases. Limited evidence
regarding vitamin D deficiency exists within the Chinese population. The present study aims to examine the
association between serum vitamin D concentrations and cardiometabolic risk factors in the young and
middle-aged, urban Chinese population
Methods: The cross-sectional relationships between serum 25-hydroxyvitamin D [25(OH)D] concentrations and
indices of adiposity and cardiometabolic risk factors (e.g., body mass index, waist circumference, fasting plasma
glucose, etc.) were evaluated in 601 non-diabetic adults.
Result: Vitamin D deficiency or insufficiency was present in 66% of the tested population, and serum 25(OH)D
levels were lower in patients who were overweight/obese or suffered metabolic syndrome when compared to
individuals of healthy weight without metabolic syndrome (24.08 ± 8.08 vs 31.70 ± 11.77 ng/ml, 21.52 ± 6.9 vs
31.74 ± 10.21 ng/ml respectively). 25(OH)D was inversely associated with waist circumference, fasting glucose,
fasting insulin, triglycerides and LDL-cholesterol, and it was positively associated with HDL-cholesterol in a
multivariable-adjusted regression model.
Conclusion: Vitamin D deficiency is common in the young and middle-aged, urban Chinese population, with high
prevalence in overweight/obese individuals and patients with metabolic syndrome. Low vitamin D concentration
was associated with indices of adiposity and cardiometabolic risk factors. Further studies are warranted to elucidate
the cause-effect relation between vitamin D status, obesity and related metabolic disorders.
Trial registration: Current Controlled Trials (ISRCTN21527585)
Keywords: Obesity, Vitamin D deficiency, Metabolic syndrome
Introduction
Altered vitamin D homeostasis is associated with
increased risk of developing obesity [1-4], hypertension
[5,6], glucose intolerance and metabolic syndrome [7].
Additionally, hypovitaminosis D has been reported as a
risk factor for increased cardiovascular events [8] and
was independently associated with all-cause mortality
based on analysis of the Third National Health and
Nutrition Examination Survey (NHANES III) data.
Vitamin D status, which was assessed by serum 25-
hydroxyvitamin D [25(OH)D] concentrations, differs
among ethnic groups, with African-Americans, Hispa-
nics and Asians, having a greater prevalence of hypovita-
minosis D [9,10]. Lower vitamin D levels among these
groups may be explained in part by darker skin pigmen-
tation [11]. The relationship between hypovitaminosis D
and metabolic traits, such as insulin resistance, appear
to vary among different ethnicities. NHANES III data
[12] showed an inverse association between vitamin D
status and insulin resistance in non-Hispanic whites and
Mexican Americans, but the inverse relationship did not
hold in African-Americans Americans. Limited informa-
tion exists concerning the relationship between vitamin
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D status and metabolic risk factors among Asian popula-
tions. Because of the increased risk of vitamin D defi-
ciency among the northern Chinese population due
to their darker skin pigment and northern latitude,
coupled with the increasing incidence of obesity and
metabolic syndrome, we seek to determine if hypovita-
minosis D is associated with metabolic risk factors in the
Chinese population.
This study aims to 1) determine the cross-sectional as-
sociation of vitamin D status with indices of adiposity
and metabolic risk factors in a representative sample of
urban, young and middle-aged, non-diabetic adults res-
iding in northern China, and 2) evaluate the prevalence
of subclinical vitamin D deficiency in this cohort.
Methods
Study sample
This study included 601 adults that received health
examinations in Jinan Central Hospital. Inclusion criteria
were as follows: 35–60 years old, living in Jinan (latitude
36.6) for more than 5 years, employed in an office set-
ting, and > 13 years of education. Exclusion criteria
included the following: use of vitamin D and calcium
supplementation within 60 days of screening, current
use of cigarettes (self-reported), alcohol abuse (defined
as >14 drinks/week for men, >7 drinks/week for
women), diagnosis of overt diabetes, cardiovascular dis-
ease or other systematic disease, use of medications that
influence vitamin D, glucose, lipid profiles or blood pres-
sure, or engaging in ≥20 min of strenuous physical activ-
ity or exercise that causes excessive breathing and
sweating≥ 1 time per week. This study was approved by
the Jinan Central Hospital Ethics Committee and was per-
formed in accordance with the declaration of Helsinki.
All subjects provided written informed consent.
Clinical assessment
Body mass index (BMI) was categorized as normal
weight (<24 kg/m2) , overweight (24–28 kg/m2) and
obese (>28 kg/m2), according to the criteria for Chinese
individuals [13]. Metabolic syndrome was identified
using the updated National Cholesterol Education Pro-
gram Adult Treatment Panel III criteria for Asian Amer-
icans [14] and includes presentation of three or more
ofthe following components: 1) waist circumference
≥90 cm for men or ≥80 cm for women; 2) triglyceride
≥1.7 mmol/L; 3) HDL cholesterol <1.03 mmol/L for
men or <1.30 mmol/L for women; 4)blood pressure
≥130/85 mmHg; and 5) fasting glucose ≥5.6 mmol/L.
Vitamin D nutritional status was based on 25(OH)D
levels, which were assessed as “deficient”(<20 ng/ml),
“insufficient”(20-30 ng/ml) or “sufficient”( >30 ng/ml)
[15].
Protocol
Anthropometric measures (weight, height, and waist cir-
cumference) and blood pressure were calculated on all
participants. A fasting blood sample was collected in
November and December for measurement of serum 25
(OH)D, plasma glucose, insulin, triglyceride, LDL-
cholesterol and HDL-cholesterol concentrations. The
homeostasis model assessment of insulin resistance
(HOMA-IR) was calculated from fasting insulin and glu-
cose levels [16].
Laboratory analyses
Serum samples were obtained in the morning after an
overnight fast and frozen at −80°C. Serum 25(OH)D and
insulin were measured by double antibody radio-
immunoassay (DiaSorin, Stillwater, MN, and Linco Re-
search, St. Charles, MO) with quality control materials
provided by the manufacturer. The inter-assay coeffi-
cient of variation for 25(OH)D and insulin were 9.3%
and 6.7% respectively. Plasma glucose, triglycerides and
HDL cholesterol were measured by enzymatic colorimet-
ric assay on a Bayer 2400 chemistry analyzer (Bayer Cor-
poration). LDL cholesterol was calculated using the
Friedwald equation. All of the intra- and inter-assay
coefficients of variation were <10%.
Statistical analyses
Descriptive characteristics for participants are expressed
as median (interquartile range) for continuous variables
with skewed distribution, means (SD) for continuous
variables with normal distribution and percent for cat-
egorical variables. Some variables (body mass index,
waist circumference, fasting insulin, homair, and HDL)
were logarithmically transformed when analyzed. Com-
parisons of anthropometric and metabolic characteristics
were made using unpaired t-test or rank-sum test
between groups with and without vitamin D deficiency.
Comparison of groups with different vitamin D statuses
were made using one-way ANOVA analysis (for continu-
ous variables with normal distribution) or rank trans-
formation test (for categorical and continuous variables
with skewed distribution).
Multivariable linear regression was performed in the
total sample to examine the association of 25(OH)D
(dependent variable) with the following clinical, anthropo-
metric, and metabolic variables (independent variables)
age, sex, BMI, waist circumference, fasting glucose, fast-
ing insulin, HOMA-IR, triglycerides, HDL cholesterol,
systolic blood pressure, and diastolic blood pressure. The
association of each variable with 25(OH)D was initially
examined with adjustment for age and sex. We then con-
ducted multivariable regression analyses with stepwise
forward selection to evaluate the independent association
of 25(OH)D with each of the clinical, anthropometric,
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and metabolic variables listed above. A P value < 0.10
was the significance criterion for covariates to enter and
remain in the regression model.
Results
Clinical and biochemical characteristics of the 601
included subjects are shown in Table 1. The mean age of
participants was 50 years. Approximately one fourth of
the participants were female, and the mean 25(OH)D
concentration was 26.91 ng/ml. 398 subjects (66%) had
25(OH)D concentrations of 30 ng/ml or less, and
vitamin D deficiency (serum 25(OH)D concentration
< 20 ng/ml) was present in 172 subjects (28.6%). 63% of
the cohort were overweight/obese, and 44% of the tested
population suffered from metabolic syndrome. Vitamin D
insufficiency and deficiency were present in 76.2% and
88.3% in overweight/obese and patients with metabolic
syndrome respectively.
We categorized the subjects using the referenced vita-
min D nutritional status cutoff (as described in methods)
into vitamin D deficiency, insufficiency and sufficiency
groups which have no significant difference in age and
sex (Table 2), this definition was based on the fact that
the serum iPTH will rise significantly once the serum 25
(OH)D level drops to less than 30 ng/ml [17], and those
less than 20 ng/ml is likely to have clinically skeletal
effects of vitamin D deficient state. The vitamin D defi-
ciency group had significantly greater waist circumfer-
ence, BMI, fasting plasma glucose, insulin, HOMA-IR,
triglycerides, and diastolic blood pressure and lower
HDL cholesterol compared to vitamin sufficiency and in-
sufficiency groups. LDL cholesterol and systolic blood
pressure were significantly lower in the vitamin D suffi-
ciency group compared to the two other groups, but
there was no significant difference between vitamin D
deficiency and insufficiency groups. 15.2% individuals of
the vitamin D sufficiency group suffered from metabolic
syndrome, but for vitamin D insufficiency and deficiency
groups, the incidence rate of metabolic syndrome was
higher (48.6% and 72.6% respectively).
The participants were also divided into metabolic syn-
drome (MS) and non-metabolic syndrome (non-MS)
groups according to the criterion described in methods.
The 25(OH)D level in MS group (21.52 ± 6.9 ng/ml) was
significantly lower compared to individuals without
metabolic syndrome (31.74 ± 10.7 ng/ml, P < 0.05). The
incidence rate of vitamin D deficiency and insufficiency
was higher in MS group compared to non-MS group
(88.3 % vs. 48.6%).
The associations of 25(OH)D with clinical and meta-
bolic traits are shown in Table 3. 25(OH)D was nega-
tively related to BMI after adjusted for age and sex.
Significant inverse associations were noted between 25
(OH)D and each of the remaining clinical and metabolic
covariates, including waist circumference, fasting glu-
cose, fasting insulin, HOMA-IR, triglycerides, LDL chol-
esterol and systolic blood pressure, after adjusted for
age, sex and BMI. Additionally, serum 25(OH)D was
positively associated with HDL cholesterol.
Results of the stepwise multivariable regression model
are shown in Table 4. Because of the larger variance
observed for HOMA-IR and its collinear relationship
with fasting insulin (r = 0.987, P < 0.0001), HOMA-IR
was excluded from the stepwise multivariable regression
model. Systolic and diastolic blood pressure did not
meet significance requirements for entry into the model,
and therefore, were not included (P = 0.83, P = 0.75
respectively). All of the remaining variables entered into
and remained significant in the stepwise forward regres-
sion model, including age, sex, BMI, waist circumfer-
ence, fasting glucose, fasting insulin, triglyceride, total
cholesterol, HDL cholesterol and LDL cholesterol.
For the whole tested population, higher 25(OH)D was
significantly associated with male sex, younger age and
lower BMI. The relationship of 25(OH)D with several
markers of metabolic disorder, such as waist circumfer-
ence, fasting glucose, fasting insulin, triglyceride, HDL
cholesterol and LDL cholesterol, remained significant in
models adjusted for sex, age and BMI. For the sex spe-
cific multiple adjusted regression analysis, 25(OH)D was
negatively related to age, BMI, WC, fasting plasma glu-
cose, fasting insulin, triglyceride, and positively to HDL
(P = 0.008) for male. And 25(OH)D was negatively
related only to fasting plasma glucose, fasting insulin,
triglyceride for female.
Discussion
Findings from this study suggest that hypovitaminosis D
is relatively common among young and middle-aged,
Table 1 Characteristics of samples
Total (n = 601)
Age (years) 49.36 ± 7.10
Female (%) 25.46%
Waist circumference (cm) 87(80–93)
BMI (kg/m2) 25.21(22.94-27.19)
Fasting plasma glucose (mmol/L) 5.2(5.6-5.9)
Fasting insulin (μIu/ml) 12.83(8.29- 19.53)
HOMA-IR 3.14 (2.05- 4.8)
Triglycerides (mmol/L) 1.58 (1.15- 2.25)
HDL cholesterol (mmol/L) 1.2(1.03-1.4)
LDL cholesterol (mmol/L) 3.32(2.86-3.84)
Systolic blood pressure (mmHg) 132(119–144)
Diastolic blood pressure (mmHg) 85(75–93)
25(OH)D (ng/ml) 26.91(10.41)
Data are median (interquartile range), mean (SD) or n(%).
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northern Chinese individuals living in an urban environ-
ment, especially those who are obese and have metabolic
syndrome. Additionally, we found vitamin D status was
significantly associated with glucose homeostasis indices
and lipid profile, which remained after adjustment
for BMI.
This study consisted of a high risk population for
metabolic syndrome, namely a young and middle aged,
urban cohort who were office workers and physically in-
active [14]. The prevalence of vitamin D deficiency and
insufficiency was 28.6% and 37.6% respectively which
is not as striking as the 69.2% and 24.4% for vitamin D
deficiency and insufficiency respectively as previously
reported in Chinese population by Lu et al. [18]. This
deviation perhaps derived in part from the older age of
participants in their study (50–70 years old) compared
to the present study (35–60 years old). Additionally, the
present study excluded patients who have overt diabetes,
CVD and currently use anti-hypertensive medication
and lipid drugs, which means participants in the present
study have better metabolic conditions compared to Lu’s
study. Although lower 25(OH)D levels were positively
related to female sex in multivariable analysis, there was
no significant difference in vitamin D statuses between
males and females in our present study (data not
shown). This may be attributed to the older age and
higher BMI levels in the male group when compared to
the female group, which may eliminate the advantage of
male sex on vitamin D metabolism.
We also observed a greater prevalence of hypovitami-
nosis D amongst overweight/obese individuals. Even
among lean individuals, lower vitamin D concentrations
were associated with greater BMI, which is similar to
results reported for other ethnic groups [19]. The
observed association of low 25(OH)D with BMI may be
due in part to the increased distribution volume of lipid
soluble vitamin D to fat. There are also some experi-
mental data that suggest vitamin D deficiency pro-
motes lipogenesis through elevated parathyroid hormone
[20] and could possibly modulate adipogenesis through
vitamin D receptor-dependent inhibition of critical
molecular components involved in differentiation and
Table 2 Characteristics of samples according to vitamin D status
Vitamin D status
Sufficiency Insufficiency Deficiency
n 203 226 172
Age (years) 47.98 ± 7.27 50.29 ± 6.40 49.77 ± 7.54
Female (%) 30 23 23
Waist circumference (cm) 80(76–86) 88(81–93)* 92(87.5-99)*#
BMI (kg/m2) 23.72(21.77-25.69) 25.21(23.75-27.12)* 26.63(24.79-29.07)*#
Fasting plasma glucose (mmol/L) 5.3(5.1-5.9) 5.6(5.3-5.9) * 5.9(5.5-6.15) *#
Fasting insulin (μIu/ml) 9.83(6.68-12.96) 13.75(9.68-18.57)* 18.13(11.18-28.63)*#
HOMA-IR 2.28(1.56-3.09) 3.41(2.44-4.73) * 4.77(2.84-7.38) *#
Triglycerides (mmol/L) 1.2(0.95-1.49) 1.71(1.21-2.2) * 2.36(1.61-3.20) *#
HDL cholesterol (mmol/L) 1.31(1.14-1.52) 1.18(1.02-1.37) * 1.10(0.93-1.26) *#
LDL cholesterol (mmol/L) 2.25(2.8-3.69) 3.29(2.86-3.72) * 3.49(2.97-4.20) *
Systolic blood pressure (mmHg) 125(115–137) 135(120–147) * 136.5(126.5-150) *
Diastolic blood pressure (mmHg) 80(71–88) 85(76–94) * 90(80–96) *#
25(OH)D (ng/ml) 38.36(8.09) 25.07(2.63) * 15.81(3.06) *#
Metabolic syndrome(%) 15.27 48.67 72.67
Waist circumference, BMI, Fasting insulin, HOMA-IR, HDL cholesterol, LDL cholesterol were log-transformed before analysis. * P < 0.05 compared to vitamin D
sufficiency group; # P < 0.05 compared to vitamin D insufficiency group.
Table 3 Age and sex adjusted relations of serum 25(OH)D





Waist circumference −0.63(0.06) <0.0001
Fasting plasma glucose −6.53(0.67) <0.0001
Fasting insulin −0.39(0.04) <0.0001
HOMA-IR −1.49(0.14) <0.0001
Triglycerides −2.51(0.27) <0.0001
HDL cholesterol 8.67(1.43) <0.0001
LDL cholesterol −1.33(0.49) 0.0067
Systolic blood pressure −0.06(0.02) 0.0162
Diastolic blood pressure −0.07(0.03) 0.0455
*Coefficients represent change in 25(OH)D (ng/ml) for an increase in the
value of the predictor variables shown (1-SD increase for continuous
predictor variables).
Yin et al. Nutrition Journal 2012, 11:68 Page 4 of 7
http://www.nutritionj.com/content/11/1/68
maturation of adipocytes [21]. Thus, increases in body
fat mass could worsen the state of vitamin D deficiency,
which may further increase body fat mass through vita-
min D receptor regulation of pathways that are yet to
be confirmed.
In this study, we observed significant associations of
serum 25(OH)D with components of metabolic syn-
drome including waist circumference, triglyceride, HDL
cholesterol and fasting glucose, but we did not find asso-
ciations with blood pressure, even after adjusting for adi-
posity, which is in accordance with the findings from
both the Cross-Sectional Study in the 1958 British Birth
Cohort [7] and the NHANES III [22] study. Lu et al.
[18] also noted that low 25(OH)D level increased risk
for metabolic syndrome. Similar to result in Lu et al.
study, the present study showed that the association be-
tween 25(OH)D and predictor variables were stronger
in men than in women. However, results are conflicting
as some previous investigations have only observed asso-
ciations of 25(OH)D with anthropometric markers of
metabolic syndrome (i.e. WC and BMI), but not with
any of the clinical or serum parameters (i.e. fasting glu-
cose, triglycerides, HDL cholesterol or blood pressure)
[23]. Because excess weight is a major component of
metabolic syndrome, the associations noted in our study
could reflect an association of serum vitamin D with
excess weight. Regardless of the associations with compo-
nents of metabolic syndrome, we also found a significant
inverse association for 25(OH)D with LDL-cholesterol,
which was not included in Lu’s study. LDL-cholesterol is
perhaps the most important risk factor of cardiovascular
disease, and thus, this result underscores the importance
of hypovitaminosis D as a correlate of cardiovascular dis-
ease as has been observed in other investigations [24].
Insulin resistance is considered a likely mechanism
causing metabolic syndrome and has been implicated in
increased cardiovascular disease [25]. In the present
study, insulin resistance as determined by HOMA-IR
was significantly greater in vitamin D deficient subjects.
Although prior data are conflicting [26], some studies
did observe an inverse association between concentra-
tions of vitamin D and insulin resistance in different eth-
nic populations and age groups [27-29]. However, results
from the Framingham Heart study found that adjusting
for measures of central adiposity diminished the associ-
ation between 25(OH)D and proxy measures of insulin
sensitivity [19], implying that obesity may still the most
important factor influencing the relationship between
insulin sensitivity and vitamin D status. A study in an
African-American cohort [30] suggested that vitamin D
may have more influence on peripheral, rather than
hepatic, insulin sensitivity, through the measurement of
the OGTT-derived whole body insulin sensitive index
(Matsuda index). Therefore, direct measures of insulin
sensitivity, such as euglycemic clamp, frequently sampled
intravenous glucose tolerance test (FSIGT,) or glucose
tracer studies, will be needed to confirm results.
Several limitations of this study merit consideration.
The results of our study may not be generalized to all
racial/ethnic groups or age groups given that our sample
was northern Chinese and young to middle-aged. Multi-
variable analyses were unable to adjust for the parathyroid
hormone because this was not measured in our sample.
Notwithstanding the above limitations, the present
study had several strengths. We used a work and lifestyle-
based sample not selected on the basis of adiposity-
related traits, cardiovascular disease risk factors, or
vitamin D status. Our participants were young and mid-
dle aged, urban Chinese office workers, who were physic-
ally inactive with a high education level, traits indicating
high risk for obesity and related metabolic disorders. All
Table 4 Stepwise multivariable adjusted relationships of
clinical and metabolic covariates with serum 25(OH)D
Coefficient(SE)* Beta P
All (N= 601)
Age −0.24(0.05) −0.164 <0.0001
Sex −6.77(0.88) −0.286 <0.0001
BMI −0.56(0.16) −0.160 0.0004
Waist circumference −0.22(0.07) −0.209 0.0015
Fasting plasma glucose −4.63(0.61) −0.239 <0.0001
Fasting insulin −0.17(0.04) −0.164 <0.0001
Triglycerides −1.46(0.26) −0.193 <0.0001
HDL cholesterol 4.50(1.27) 0.121 0.0004
LDL cholesterol −1.20(0.41) −0.089 0.0034
Men (N=448)
Age −0.30(0.06) −0.197 <0.0001
BMI −0.59(0.18) −0.164 0.001
Waist circumference −0.28(0.075) −0.233 <0.0001
Fasting plasma glucose −3.87(0.71) −0.16 <0.0001
Fasting insulin −0.16(0.04) −0.154 0.001
Triglycerides −1.23(0.34) −0.177 <0.0001
HDL cholesterol 4.28(1.61) 0.110 0.008
Women (N=153)
Fasting plasma glucose −7.42(1.28) −0.382 <0.0001
Fasting insulin −0.21(0.09) −0.188 0.025
Triglycerides −3.38(1.35) −0.228 0.014
*Coefficients represent change in 25(OH)D (ng/ml) for an increase in the value
of the predictor variables shown (1-SD increase for continuous predictor
variables). The stepwise multivariable model was adjusted for the following
variables: age, sex, BMI, waist circumference, fasting glucose, fasting insulin,
triglycerides, HDL cholesterol, and LDL cholesterol. R2 for the regression
model was 0.479, 0.472 and 0.564 for the whole population, men and women
groups respectively.
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the participants lived in the same city for more than
5 years and blood samples were collected within two
months (November and December), eliminating sea-
sonal and geographic effects on the results. Our study
excluded overt diabetes, CVD, hypertension and hyper-
lipidemia, which need medication to control, so this is a
key population for primary prevention of type 2 diabetes
and CVD. Intervention to this population would have
significant impact on the control of chronic metabolic
disease in a cost-effective manner.
Although there is mounting evidence linking vitamin
D deficiency with obesity and related metabolic abnor-
malities, vitamin D intervention trials have had mixed
results, which are likely due to different study popula-
tions, vitamin D replacement dosage, and intervention
length. It is also possible that the link between vitamin
D and cardiometabolic risk factors may reflect the fact
that both vitamin D deficiency and metabolic disorders
are prone to cluster in obese populations.
Conclusions
25-hydroxyvitamin D deficiency is associated with obes-
ity and related cardiometabolic risk factors in middle-
aged, urban Chinese adults. In the future, randomized
controlled trials are needed to establish a cause-effect
relationship between vitamin D deficiency, obesity and
its metabolic consequence and to evaluate the use the
vitamin D3 in metabolic syndrome patients.
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